Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP300970.RA6Yx4JKOWtd-vFbdV-xNpyPHoYMfAPVAhx1qAq2cwmq4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP300970.RA6Yx4JKOWtd-vFbdV-xNpyPHoYMfAPVAhx1qAq2cwmq4130_assertion type Assertion NP300970.RA6Yx4JKOWtd-vFbdV-xNpyPHoYMfAPVAhx1qAq2cwmq4130_head.
- NP300970.RA6Yx4JKOWtd-vFbdV-xNpyPHoYMfAPVAhx1qAq2cwmq4130_assertion description "[High levels of Tissue Inhibitor of Metalloproteinases-1 (TIMP1) are associated with poor prognosis, reduced response to chemotherapy, and, potentially, also poor response to endocrine therapy in breast cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP300970.RA6Yx4JKOWtd-vFbdV-xNpyPHoYMfAPVAhx1qAq2cwmq4130_provenance.
- NP300970.RA6Yx4JKOWtd-vFbdV-xNpyPHoYMfAPVAhx1qAq2cwmq4130_assertion evidence source_evidence_literature NP300970.RA6Yx4JKOWtd-vFbdV-xNpyPHoYMfAPVAhx1qAq2cwmq4130_provenance.
- NP300970.RA6Yx4JKOWtd-vFbdV-xNpyPHoYMfAPVAhx1qAq2cwmq4130_assertion SIO_000772 23881388 NP300970.RA6Yx4JKOWtd-vFbdV-xNpyPHoYMfAPVAhx1qAq2cwmq4130_provenance.
- NP300970.RA6Yx4JKOWtd-vFbdV-xNpyPHoYMfAPVAhx1qAq2cwmq4130_assertion wasDerivedFrom befree-20140225 NP300970.RA6Yx4JKOWtd-vFbdV-xNpyPHoYMfAPVAhx1qAq2cwmq4130_provenance.
- NP300970.RA6Yx4JKOWtd-vFbdV-xNpyPHoYMfAPVAhx1qAq2cwmq4130_assertion wasGeneratedBy ECO_0000203 NP300970.RA6Yx4JKOWtd-vFbdV-xNpyPHoYMfAPVAhx1qAq2cwmq4130_provenance.